Cardiovascular conditions such as strokes or heart attacks are among the most common causes of death in Germany. They inhibit or prevent blood coagulation, which in turn prevents the formation of blood clots and thus also life-threatening medical emergencies such as strokes or heart attacks. Here again, a higher level of S1P in the blood resulted in lower clotting activity, which implies a reduced risk of strokes or heart attacks. “Accordingly, we will be able to protect individuals from strokes and heart attacks without increasing the risk of bleeding associated with common blood thinners.” DOI: 10.1126/sciadv.aea9826Bilder<Professor Dr Amin Polzin, Lead author Dr Marcel Benkhoff, Dr Philipp Mourikis (all Departement of Ca ...